Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
059
|
Date of Entry 12/19/2022
|
FR Recognition Number
|
13-127
|
Standard | |
ANSI AAMI UL 2800-1-3:2022 Standard for Interoperable Item Integration Life Cycle |
|
Scope/Abstract2.1 This Standard is applicable to interoperable medical products, including assembled systems of interoperable medical products that comprise or are intended to be incorporated into interoperable medical systems within an interoperable environment. 2.2 This standard specifies a baseline set of integration lifecycle requirements for assuring safe and secure interoperability for interoperable medical systems.
|
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
FDA recognition of ANSI, AAMI, UL 2800-1:2019 [Rec# 13-109] will be superseded by recognition of ANSI, AAMI, UL 2800-1:2022 [Rec# 13-121], 2800-1-1:2022 [Rec# 13-125], 2800-1-2:2022 [Rec# 13-126], and 2800-1-3:2022 [Rec# 13-127]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 13-109] until December 17, 2023. After this transition period, declarations of conformity to [Rec# 13-109] will not be accepted. |
|
Relevant FDA Guidance and/or Supportive Publications*
1. Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Guidance for Industry and Food and Drug Administration Staff. Issued September 2017
2. ANSI/AAMI/UL 2800-1:2022 - Standard for Medical Device Interoperability
3. ANSI/AAMI/UL 2800-1-1:2022 - Standard for Risk Concerns for Interoperable Medical Products
4. ANSI/AAMI/UL 2800-1-2:2022 - Standard for Interoperable Item Development Life Cycle
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organizations
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |